Text Size

Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2006 by Hadassah Medical Organization.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00299637
First received: March 5, 2006
Last updated: November 29, 2006
Last verified: March 2006
History of Changes
  Purpose

This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.


Condition Phase
Chorioamnionitis
 Phase 0

Study Type: Observational
Study Design: Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis During Labor Comparing to Fetuses to Healthy Mothers.

Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment: 34
Study Start Date: October 2006
Estimated Study Completion Date: December 2007
Detailed Description:

This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.

MCA flow parameters will be evaluated during labor of women with and wthout chorioamnionitis

  Eligibility

Ages Eligible for Study:   20 Years to 45 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • women giving birth week 37-42
  • healthy
  • one fetus

Exclusion Criteria:

  • more than one fetus
  • IUGR
  • illness or damage to fetus
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00299637

Contacts
Contact: david mankuta, MD mankuta@yahoo.com

Locations
Israel
Haddasah Medical Organization Recruiting
Jerusalem, Israel, 12000
Contact: David Mankuta            
Principal Investigator: David Mankuta            
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Study Chair: David Mankuta, MD Hadassah Medical Organization
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00299637     History of Changes
Other Study ID Numbers: MCA chorioamnionitis HMO-CTIL
Study First Received: March 5, 2006
Last Updated: November 29, 2006
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Chorioamnionitis
Fetal Diseases
Pregnancy Complications
 Fetal Membranes, Premature Rupture
Obstetric Labor Complications
Placenta Diseases

ClinicalTrials.gov processed this record on June 18, 2013